some underlying immunity now, so those developments might be extended further. therefore, the importance of the laboratory and experimentation, i think, of the laboratory and experimentation, ithink, it of the laboratory and experimentation, i think, it is more of an issue at the moment because of the gap in clinical data. the downside is that we need to be cautious in over interpreting it. i think, rather, the laboratory data should be used to confirm or reject clinical findings. should be used to confirm or reject clinicalfindings. for example, the clinical findings. for example, the observations clinicalfindings. for example, the observations in south africa while i was sceptical initially, do seem to fit with the things i have been observing in my laboratory. 25nd fit with the things i have been observing in my laboratory. and in terms of restrictions, _ observing in my laboratory. and in terms of restrictions, you - observing in my laboratory. and in terms of restrictions, you took - terms of restrictions, you took touched on that in your first answer. as a scientist, where are you in terms of whether we need more restrictions now with these levels in the community? t restrictions now with these levels in the community?— restrictions now with these levels in the community? i don't think that the levels in — in the community? i don't think that the levels in the _ in the community? i don't think that the levels in the community - in the community? i don't think that the levels in the community per- in the community? i don't think that the levels in the community per se i the levels in the community per se are the issue. i think the thing we need to be preventing or defending